Impiricus Raises $3M in Seed Funding Led by FCA Venture Partners

By Impiricus
May 23, 2022

In 2022, Impiricus closed a $3 million Series Seed financing round led by FCA Venture Partners, with participation from Surface Ventures.

“Impiricus clearly fits our investment thesis,” said Todd Johnson, Partner at FCA Venture Partners. “A bold leadership team with a powerful product and the potential to reshape pharma-HCP collaboration.”

The funding supports our ongoing mission to transform healthcare communication by connecting physicians and pharma through real-time, ethical, AI-powered technology.

READ OUR CONTENT

News And Insights

Press

Impiricus CEO & Co‑Founder Dr. Osama Hashmi Named to Forbes Technology Council

Impiricus, the leading AI‑powered HCP Engagement Engine, today announced that its CEO...

Article

HIMSSCast: The hurdles of AI in the pharma industry

“As seen on Healthcare Finance News” Pharma faces regulations and stringent rules...

Press

New York Stock Exchange Spotlights Impiricus for Unprecedented Impact for Physicians and Pharma

NEW YORK, NY — December 22, 2025 — Impiricus, the leading AI-powered...